Welcome Message

We are excited to reveal the eagerly anticipated 34^th Euro Congress on Neurologists and Psychiatrists set to take place on April 10-11, 2025, in Paris, France. This year’s event features the cutting-edge theme "Exploring the Intersection of Neurological and Psychiatric Disorders," aimed at presenting new ideas, techniques, and strategies that will transform your professional practices. Euro Neuro 2025 will bring together leading experts in Psychiatry and Neurology, creating a unique platform for collaboration and knowledge sharing.

The conference offers an exceptional opening for researchers, experts, university professors, psychiatrists, neurologists, psychologists, and students to engage in a comprehensive program that includes lectures, presentations, poster sessions, and discussions. These sessions are designed to foster extensive knowledge exchange and innovation in the field. It’s a perfect event to share your research, gain recognition with certificates endorsed by our esteemed organizing committee, and expand your professional network.

No other event offers the remarkable line up of keynote speakers, distinguished participants, and engaging content that we provide. This conference is a prime gateway for academics from universities and institutes to connect with peers and enhance their scholarly networks. We encourage you to confirm your participation and join us in the beautiful city of Paris, France, for this outstanding event.

Target audience

• Neurosurgeons
• Neurobiologists
• Neurology Specialists
• Psychiatrists
• Neuro-oncology Experts
• Neuro-ophthalmologists
• Molecular Neurology Researchers
• Medical Doctors
• Surgeons
• Occupational Therapy Professionals
• Paediatric Neurologists
• Healthcare Practitioners
• Researchers and University Faculty
• Entrepreneurs in the Health Sector
• Industry Experts
• Diagnostic Laboratory Professionals
• Undergraduate and Graduate Students

Event Highlights:

Notable Keynote Speakers: Learn from distinguished thought leaders in the field.

Esteemed Participants: Engage with leading experts and fellow professionals.

Compelling Content: Explore a program covering the latest and most relevant topics in neurology and psychiatry.

This conference offers an exceptional platform for scholars and professionals to share ideas and deepen their knowledge. Seize this rare pathway to enhance your expertise and broaden your professional network.

Register Now:  To reserve your spot, please confirm your attendance and consider bringing your colleagues along. We eagerly anticipate your involvement in making this congress an unforgettable experience.

Best Regards,
Program Manager
Euro Neuro 2025

About Conference

It is great delight to announce the 34^th Euro Congress on Neurologists and Psychiatrists, scheduled for April 10-11, 2025, in Paris, France. Join us live to enhance your understanding of the latest research in neurology and psychiatry, with a focus on the theme "Exploring the Intersection of Neurological and Psychiatric Disorders."

This conference provides an exceptional platform to share, explore, and exchange knowledge, fostering research collaborations and networking opportunities. It is designed for neurologists, scientists, psychiatrists, surgeons, and pharmaceutical companies from around the world. Don’t miss this unique way to contribute and stay updated on the latest advancements in the field.

EURO NEURO 2025 offers to engage in discussions with expert speakers, network with fellow delegates, explore presentations from emerging researchers, experience exhibitor showcases, and participate in oral and poster presentations, among other benefits. This year’s Euro Neuro Congress aims to bring together academic researchers, specialists, and scientists to share insights and experiences on all aspects of the nervous system and brain functions.

The conference is focused on delivering the latest insights into neuroscience developments, providing a platform to explore solutions for unresolved challenges in brain research. By attending, you will gain valuable scientific experiences and foster global collaborations. Join us for an enriching exploration of cutting-edge neurological advancements.

Why to Attend?

Exclusive Insights: Interact with prominent experts and stay updated on the most recent breakthroughs in neurology and psychiatry.

Holistic Agenda: Take part in a variety of events, including lectures, presentations, poster sessions, and discussions, all aimed at promoting in-depth knowledge sharing.

Professional Recognition & Networking: Present your research, receive certificates endorsed by our prestigious organizing committee, and connect with leading researchers, professors, neurologists, psychiatrists, and students from around the world.

Sessions/ Tracks

Track 1: Neuropsychiatric Disorders and Addiction to Psychotropic Substances

Neuropsychiatric disorders and addiction to psychotropic substances are often intertwined, creating a complex cycle that negatively impacts mental health. Conditions like depression, anxiety, and schizophrenia can increase susceptibility to substance abuse, as individuals may self-medicate to cope. This bidirectional relationship leads to dual diagnosis, where both substance use disorders and mental health conditions are present. Effective treatment requires integrated care that addresses both the addiction and underlying psychiatric issues through medication, therapy, and support. 

• Addiction Neuroscience
• Comorbid Disorders
• Addiction Stigma & Mental Health
• Genetics of Addiction

Track 2: Neurological Disorders, Stroke and CNS Injury

Neurological disorders, stroke, and CNS injuries are serious health conditions affecting the brain, spinal cord, and nerves. Disorders like Alzheimer's, Parkinson's, Epilepsy and Multiple Sclerosis can impair cognitive, motor, and sensory functions due to genetic, infectious or degenerative causes. Stroke, caused by interrupted blood flow to the brain, leads to brain cell damage and deficits in movement, speech, and cognition. CNS injuries, often from trauma, can result in paralysis, cognitive impairments, or chronic pain.

• Neurovascular Diseases
• Traumatic Brain Injury (TBI)
• Neuroprotective Therapies
• Chronic Neurological Conditions
• CNS Injury Recovery Mechanisms
• Stroke Prevention & Management
• Neuroplasticity in CNS Repair

Track 3: Digital Mental Health Interventions

Digital mental health interventions use technology to provide accessible support for mental health challenges. These tools include mobile apps, online therapy, virtual support groups, and digital CBT, offering convenient and often anonymous resources for managing conditions like anxiety and depression. They provide immediate support, track progress, and deliver personalized content, making mental health care more accessible, particularly for those in remote or underserved areas.

• Tele psychiatry
• E-Health in Cognitive Behavioural Therapy
• Gamification in Mental Health Interventions
• AI and Mental Health Diagnostics
• Digital Tools for Depression & Anxiety

Track 4: Forensic Psychiatry

Forensic psychiatry is a specialized discipline that connects mental health with the legal system. It involves assessing and treating individuals involved in legal matters, such as criminal cases or civil disputes. Forensic psychiatrists evaluate mental competency, criminal responsibility, and provide expert testimony. They also work with offenders in correctional settings to address mental illness, reoffending risk, and rehabilitation. Forensic psychiatry ensures appropriate care while informing legal decisions with accurate psychological evaluations, balancing justice and mental health.

• Psychopathy and Antisocial Behaviour
• Ethics in Forensic Psychiatry
• Juvenile Delinquency and Mental Health
• Insanity Defense and Legal Implications
• Mental Health and Criminal Behaviour

Track 5: Innovations in Spine Surgery

Recent developments in spine surgery have resulted in improved outcomes, reduced recovery periods, and enhanced patient safety. Minimally invasive techniques involve smaller incisions and minimize muscle disruption, resulting in faster recovery. Robotic-assisted surgery provides enhanced precision and accuracy for intricate procedures. Advances in spinal implants, such as 3D-printed devices and stem cell therapies, improve spinal fusion and regeneration. Image-guided navigation and intraoperative monitoring ensure safer surgeries by providing real-time feedback.

• Spinal Fusion Techniques
• Spinal Biomechanics and Surgery
• Regenerative Medicine in Spine Treatment
• Spinal Deformity Correction
• Robotics in Spine Surgery

Track 6: Neuroimmunology and Neuroplasticity

Neuroimmunology and neuroplasticity are interconnected fields that explore the ways in which the immune system and the nervous system interact and affect one another. Neuroimmunology explores how immune responses impact the brain and spinal cord. The immune system can influence brain function by releasing molecules that impact neurons, inflammation, or neurodegeneration. Neuroplasticity refers to the brain's ability to reorganize itself by forming new neural connections in response to injury, learning, or environmental changes, aiding recovery after damage. Together, these fields provide insights into brain healing and potential treatments for neurological disorders.

• Cytokines and Brain Health
• Neuroinflammation in Neurological Disorders
• Autoimmune Diseases of the CNS
• Neuroimmune Interactions in Mental Health
• Therapies Targeting Neuroinflammation

Track 7: Autism Spectrum Disorders and Paediatric Neurological Disorders

Autism Spectrum Disorder (ASD) and Paediatric Neurological Disorders significantly impact a child's cognitive, social, and behavioural development. ASD is a neurodevelopmental disorder defined by difficulties in communication, social interactions, and repetitive behaviors. Early diagnosis and interventions like behavioural therapy, speech therapy, and social skills training can improve outcomes. Paediatric neurological disorders, such as epilepsy, cerebral palsy, and developmental delays, affect the brain, spinal cord, and nerves, often requiring multidisciplinary treatment.

• Genetics of Autism Spectrum Disorder
• Paediatric Epilepsy and Seizure Disorders
• Cognitive Development in Autism
• Autism and Co-occurring Disorders

Track 8: Bipolar Disorders, Anxiety disorders and Dementia

Bipolar disorder, anxiety disorders, and dementia are significant mental health conditions affecting emotional well-being, cognitive functioning, and quality of life. Bipolar disorder involves extreme mood swings between mania (elevated mood and high energy) and depression (sadness and fatigue), treated with mood stabilizers, antipsychotics, and therapy. Anxiety disorders, like generalized anxiety, panic, and social anxiety, cause excessive worry and fear, managed through cognitive-behavioural therapy, medication, and relaxation techniques. Dementia, including Alzheimer's, leads to memory and cognitive decline, with no cure but early diagnosis and treatments to manage symptoms. These disorders emphasize the importance of early intervention, personalized care, and ongoing support.

• Managing Bipolar Disorder Across Lifespan
• Psychopharmacology in Anxiety Disorders
• Early Diagnosis of Dementia
• Co-occurrence of Anxiety and Dementia
• Mood Disorders and Cognitive Function
• Biomarkers in Bipolar and Dementia

Track 9: Molecular and Cell Biology- Neurobiology

Molecular and cell biology in neurobiology studies the processes that regulate the structure, function, and communication of cells in the nervous system. It explores how molecules like neurotransmitters, proteins, and lipids influence neural development, function, and plasticity. Key topics include synaptic transmission, where signals are passed between neurons, and neurogenesis, the creation of new neurons. Researchers also examine how genetics and the environment affect brain function and neurological disorders. Advances in techniques like CRISPR and optogenetics are advancing our understanding of brain function and potential therapies for diseases like Alzheimer’s, Parkinson’s, and epilepsy.

• Neurogenesis and Brain Development
• Molecular Mechanisms of Synaptic Plasticity
• Neurotransmission and Signal Transduction
• Genetic Regulation in Neurobiology
• Cellular Models in Neuroscience
• Neuroinflammation and Neurodegeneration
• Molecular Basis of Brain Disorders
• Stem Cells and Neural Regeneration
• Epigenetics in Neurobiology
• Molecular Targets in Neurological Diseases

Track 10: Neuroinformatics and Computational Neuroscience

Neuroinformatics and computational neuroscience combine data analysis, modeling, and computational techniques to understand the brain's structure, function, and neural networks. Neuroinformatics focuses on organizing and analysing large-scale data from brain imaging, genetics, and electrophysiology to uncover brain activity patterns and biomarkers for disorders. Computational neuroscience uses mathematical models to study how neural circuits process information, generate behaviour, and adapt. These fields offer insights into sensory processing, motor control, learning, and memory. Together, they enhance brain understanding and support new approaches in diagnosing and treating neurological diseases, playing a key role in personalized medicine and neurotechnology.

• Neural Network Simulation
• AI in Neurological Research
• Neuroimaging Analysis Techniques
• Neuroscientific Data Integration

Track 11: Genetics and Epigenetics in Neurodegenerative Diseases

Genetics and epigenetics are key in understanding neurodegenerative disorders and developing potential therapies. Genetics studies inherited DNA changes that increase the risk of conditions like Alzheimer's, Parkinson's, Huntington's, and ALS, with specific mutations, such as APOE ε4 in Alzheimer's, linked to higher risk. Epigenetics explores how environmental factors and lifestyle affect gene expression without changing DNA. Modifications like DNA methylation and histone changes can impact neural function, contributing to disease progression. Research into both genetic and epigenetic factors is offering new possibilities for early detection, targeted treatments, and prevention strategies for these conditions.

• Hereditary Neurodegenerative Disorders
• DNA Methylation in Neurodegeneration
• Role of Inherited Mutations in ALS
• Epigenetic Modifications in Alzheimer's
• Gene Therapy for Neurodegenerative Diseases
• Molecular Pathways in Parkinson’s Disease
• Hereditary Neurodegenerative Disorders
• Epigenetic Regulation of Brain Aging
• Genetic Risk Factors for Dementia

Track 12: Neuroimaging and Neuroradiology

Neuroimaging and neuroradiology are vital in neuroscience and medicine, providing detailed insights into the brain and CNS. Neuroimaging includes techniques like fMRI and PET for observing brain activity, and MRI and CT for high-resolution structural images, aiding in the diagnosis of conditions like tumours, strokes, and neurodegenerative diseases. Neuroradiology, a radiology subspecialty, involves interpreting neuroimaging data for accurate diagnosis, treatment planning, and monitoring neurological disorders. Advanced imaging helps detect brain lesions, vascular malformations, and neurodegeneration. Together, these fields have transformed the understanding, diagnosis, and treatment of neurological diseases through non-invasive methods.

• Neuroimaging in Neurodegeneration
• PET and SPECT in Neuroscience
• Neuroimaging Biomarkers
• Brain Tumour Imaging
• Diffusion Tensor Imaging (DTI)

Track 13: Neurolinguistics

Neurolinguistics is the study of how the brain processes, produces, and understands language, combining neuroscience, linguistics, psychology, and cognitive science. It examines how different brain regions are involved in language functions like speaking, listening, reading, and writing. Key areas of study include the impact of brain damage (e.g., from stroke) on language abilities and how linguistic processing occurs in healthy individuals. Research has identified areas such as Broca's area (responsible for speech production) and Wernicke's area (involved in language comprehension). Neurolinguistics also explores language acquisition, multilingualism, and language disorders like aphasia and dyslexia, advancing our understanding of the brain's language mechanisms.

• Bilingualism and the Brain
• Language Disorders and Brain Damage
• Brain Areas Involved in Language
• Neuroplasticity in Language Recovery

Track 14: Drugs and the Nervous System

Drugs, including prescription medications, recreational substances, and alcohol, can significantly impact the nervous system by altering brain function, behaviour, and neurological health. Psychoactive substances interact with neurotransmitters, affecting mood, cognition, and perception. Stimulants like cocaine increase dopamine levels, leading to euphoria and potential addiction, while depressants like alcohol enhance GABA activity, inducing relaxation. Opioids reduce pain but carry risks like addiction and respiratory depression. Long-term drug use can cause structural and functional changes in the brain, contributing to neurological disorders such as addiction, memory loss, and cognitive decline.

• Drugs and Brain Receptors
• Neurotoxic Effects of Drugs
• Psychotropic Drugs and Mental Health
• Drug-Induced Neuroplasticity
• Opioids and the Nervous System
• Drugs in Neurodegenerative Diseases
• CNS Drug Delivery Systems

Track 15: Brain-Computer Interfaces (BCIs) and Neurobiotechnology

Brain-Computer Interfaces (BCIs) and neurobiotechnology are advancing fields that connect the brain to technology, with significant potential in medical treatments and human-computer interactions. BCIs allow direct communication between the brain and external devices, benefiting those with neurological impairments by enabling control of prosthetics or communication through brain signals. Neurobiotechnology, which includes BCIs, focuses on developing technologies to diagnose and treat brain disorders, such as gene editing, neurostimulation, and nanotechnology. These innovations aim to repair neural damage, enhance brain function, and treat conditions like Parkinson’s, epilepsy, and Alzheimer’s, revolutionizing both neurological treatments and human-machine interaction.

• Neuroprosthetics and Movement Control
• Neurotechnology for Rehabilitation
• Neurostimulation and Brain Modulation
• Neurogenesis and Stem Cell Therapy
• Gene Editing in Neuroscience
• Drug Delivery Systems for the CNS
• Synthetic Biology in Neuroscience

Track 16: Non-Invasive Neuromodulation

Non-invasive neuromodulation involves techniques that alter brain activity without surgery or implantation, offering a safe treatment for neurological and psychiatric disorders. Methods like transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) use magnetic fields or electrical currents to stimulate specific brain areas, helping conditions like depression, anxiety, chronic pain, and cognitive impairments. These therapies avoid the risks of invasive procedures and can be administered in clinical settings or at home. By restoring balance to disrupted neural circuits, non-invasive neuromodulation provides an alternative or complement to traditional treatments like medication and psychotherapy.

• Transcranial Magnetic Stimulation (TMS)
• Transcranial Direct Current Stimulation (tDCS)
• Neuromodulation in Mental Health
• Neuromodulation in Depression and Anxiety
• Electroconvulsive Therapy (ECT) Innovations

Track 17: Advances in Neurogenetics

Advances in neurogenetics are enhancing our understanding of the genetic causes of neurological and psychiatric disorders. By identifying genes linked to conditions like Alzheimer's, Parkinson's, epilepsy, and autism, researchers are uncovering the molecular mechanisms behind brain function and dysfunction. Technologies like genome-wide association studies (GWAS), CRISPR, and next-generation sequencing enable precise exploration of complex disorders. These advances improve early diagnosis, risk prediction, and personalized medicine, tailoring treatments to an individual’s genetics. Neurogenetics also holds promise for developing gene therapies to address genetic mutations, potentially revolutionizing the prevention, diagnosis, and treatment of neurological diseases.

• CRISPR and Neurogenetic Research
• Neurogenetics of Autism Spectrum Disorders
• Molecular Pathways in Neurogenetics
• Inherited Neurological Diseases

Track 18: Epilepsy Genetics and Epileptology

Epilepsy genetics and epileptology are interrelated fields focused on the genetic causes and clinical management of epilepsy, a disorder marked by recurrent seizures. Epilepsy genetics identifies mutations in genes related to ion channels and neurotransmitter receptors that disrupt brain activity and trigger seizures, particularly in childhood-onset epilepsy. Advances in genetic testing, like next-generation sequencing, improve diagnosis and understanding of the disorder's mechanisms. Epileptology involves the study, diagnosis, and treatment of epilepsy, using clinical expertise, neuroimaging, and genetics to develop personalized treatment plans, including medications, surgery, or neuromodulation. Together, these fields are enhancing epilepsy care and outcomes.

• Genetic Epilepsy Syndromes
• Epilepsy and Neurodevelopmental Disorders
• Epilepsy Surgery and Genetics
• Genetic Epilepsy Syndromes

Track 19: Neurodevelopmental Diseases, Neuroplasticity and Rehabiliation

Neurodevelopmental diseases, neuroplasticity, and rehabilitation are interconnected in managing conditions affecting the developing brain. Neurodevelopmental diseases, like autism, cerebral palsy, and intellectual disabilities, result from abnormal brain development and cause challenges in motor, communication, and cognitive skills. Neuroplasticity, the brain's ability to reorganize and adapt, is key to recovery, allowing the brain to compensate for lost functions. Rehabilitation therapies, including physical, speech, and occupational therapy, stimulate neuroplasticity to promote functional recovery and improve quality of life. Early intervention and ongoing support enhance neural adaptability, helping individuals maximize their potential and achieve independence.

• Attention-Deficit/Hyperactivity Disorder (ADHD)
• Synaptic Plasticity and Learning
• Plasticity in Cognitive and Motor Functions
• Neurotherapy for Neurological Disorders
• Rehabilitation after Spinal Injury

Track 20: Neuro oncology

Neuro-oncology is a medical field focused on diagnosing and treating cancers of the nervous system, including the brain, spinal cord, and peripheral nerves. It covers a variety of tumours, such as gliomas, meningiomas, and metastatic brain tumours. This field involves a multidisciplinary approach with neurosurgeons, oncologists, and radiologists working together. Advances in neuro-oncology have improved diagnostics through advanced imaging and molecular profiling, leading to personalized treatment plans. Treatment options include surgery, radiation, chemotherapy, and emerging therapies like immunotherapy and gene therapy. Ongoing research continues to improve survival rates and quality of life for patients with neurological cancers.

• Brain Tumour Genetics
• Advances in Glioma Treatment
• Paediatric Brain Tumours
• Immunotherapy in Neurooncology
• Radiation Therapy in Neurooncology
• Targeted Therapy in Brain Tumours

Track 21: Neuropsychiatric Genetics

Neuropsychiatric genetics studies the genetic factors contributing to mental health and neurological disorders. It focuses on identifying genes and mutations linked to conditions like schizophrenia, bipolar disorder, depression, autism, and Alzheimer’s disease. Advances in genetic research, including GWAS and next-generation sequencing, have revealed complex genetic networks affecting brain function and behaviour. These findings help understand how genetic predispositions and environmental factors interact to increase the risk of neuropsychiatric conditions. Neuropsychiatric genetics also enables personalized medicine, tailoring treatments to an individual's genetic makeup, with the potential to improve diagnosis, treatment, and prevention of these disorders.

• Genetics of Schizophrenia
• Genetic Risk Factors in Bipolar Disorder
• Autism Spectrum Disorder Genetics
• Genetic Risk Factors in Depression
• Epigenetics in Neuropsychiatric Disorders

Track 22: Neuromuscular Disorders

Neuromuscular disorders affect the muscles and nerves that control them, causing weakness, coordination loss, and impaired movement. Conditions like ALS, muscular dystrophies, myasthenia gravis, and peripheral neuropathies disrupt nerve-muscle communication, leading to muscle weakness and, in severe cases, paralysis. These disorders can be caused by genetic mutations, autoimmune responses, infections, or injuries. Advances in genetic research and diagnostic tools, like genetic testing and EMG, have improved diagnosis and intervention. While cures are limited, treatments such as physical therapy, medications, and emerging therapies like gene or stem cell treatments offer hope for slowing progression and improving quality of life.

• Amyotrophic Lateral Sclerosis (ALS) Genetics
• Peripheral Neuropathies
• Spinal Muscular Atrophy
• Mitochondrial Myopathies

Track 23: Translational Neurogenetics

Inherited neurological syndromes are genetic disorders that affect the nervous system, causing various symptoms and impairments. Conditions like Huntington's disease, Charcot-Marie-Tooth disease and Friedreich's ataxia are examples, each resulting from mutations that disrupt brain function, motor skills, and sensory processing. These syndromes can appear at different life stages, with some evident in childhood and others in adulthood. Genetic testing helps identify mutations for early diagnosis and family planning.

• Genetic Modelling for Drug Discovery
• Genetic Risk Factors for Neurodegeneration
• Gene Therapy in Neurological Disorders
• Neurogenetics in Psychiatric Disorders

Track 24: Inherited Neurological Syndrome

Inherited neurological syndromes are genetic disorders that affect the nervous system, caused by mutations in specific genes. These conditions, like Huntington's disease, Charcot-Marie-Tooth disease, and Friedreich's ataxia, lead to symptoms such as motor dysfunction, cognitive decline, muscle weakness, and sensory loss. Symptoms can appear at different stages of life, from childhood to adulthood. Early diagnosis through genetic testing is essential for managing these conditions and improving family planning.

• Genetic Basis of Epileptic Syndromes
• Inherited Neuromuscular Syndromes
• Genotype-Phenotype Correlations

Track 25: Neuroethics and Genetic Research

Neuroethics and genetic research explore the ethical, legal, and social implications of advances in neuroscience and genetics, particularly regarding brain understanding and manipulation. As genetic research uncovers the causes of neurological disorders, concerns about privacy, consent, and genetic discrimination grow, especially with predictive testing for conditions like Alzheimer's or Huntington's disease. Ethical dilemmas also arise with neurotechnologies and genetic therapies, such as cognitive enhancement or brain modification, raising questions about fairness and autonomy. Neuroethics addresses the risks of interventions like gene editing and stem cell therapies, emphasizing the need to balance scientific progress with ethical responsibility to protect individual rights.

• Genetic Discrimination and Neuroethics
• Ethical Considerations in Gene Therapy
• Ethics of Neurological Enhancements

Track 26: Neurogenetic Counselling and Patient Care

Neurogenetic counselling and patient care are key to managing genetic neurological disorders, helping individuals and families understand the genetic basis and implications of conditions like Huntington's disease and ataxia. Genetic counsellors provide information on inheritance patterns, risks, and testing options, while addressing emotional challenges related to uncertainty about prognosis. They work with neurologists and other specialists in a multidisciplinary approach to offer personalized care, focusing on symptom management and disease progression. By combining genetic insights with supportive care, neurogenetic counselling aids individuals in making informed decisions and navigating the complexities of living with genetic neurological conditions.

• Psychosocial Impact of Genetic Testing
• Genetic Counselling for Neurodegenerative Disorders
• Counselling for Paediatric Neurological Disorders

Market Analysis

The global psychiatric digital biomarkers market, valued at USD 631.3 million in 2024, is expected to grow at a CAGR of 24.35% from 2025 to 2030. The increasing prevalence of mental health disorders, technological advancements in digital health, and the rising demand for personalized medicine drive market growth. Wearable devices and mobile health apps are increasingly used in mental healthcare for continuous monitoring. Studies highlight the potential of digital biomarkers in improving early detection, monitoring, and personalized treatment. AI, machine learning, and smartphone data analytics further enhance the accuracy and effectiveness of mental health diagnostics and interventions.

The healthcare companies segment dominated the psychiatric digital biomarkers market with a 50.7% share in 2024, driven by the demand for personalized mental health solutions. Integrating digital biomarkers into psychiatric care allows continuous monitoring and early intervention, improving patient outcomes. For instance, NeuraMetrix’s novel typing cadence biomarker enhances diagnostic precision in neurology and psychiatry. Meanwhile, the payers segment is expected to grow rapidly due to the cost-saving potential of digital biomarkers. Payers, including Cigna and UnitedHealth, are embracing these technologies to optimize treatment plans, improve care coordination, and reduce the financial burden of mental health disorders, which cost the global economy USD 1 trillion annually.

Assessment of Neuroscience Education

In a population of 200,000, around 60,000 people are diagnosed with neurological disorders annually. Among hospitalized cases, 30% are attributed to these conditions, including stroke, epilepsy, and head injuries. Globally, 46 million people suffer from Alzheimer's disease, with over 4 million cases reported in Italy alone. This number is expected to rise to around 131.5 million by 2030. The increasing prevalence of disorders such as Parkinson's disease, Alzheimer's, and other inherited central nervous system (CNS) disorders highlights the critical need for progress in the neuroscience sector. The Italian initiative aims to expand laboratories and academic institutions to combat the growing disease rates and meet the rising demand for enhanced treatments and medications.

Neurodegenerative diseases, which impact brain neurons, are projected to grow at a compound annual growth rate (CAGR) of 4.90% from 2016 to 2023. A major factor driving this increase is the aging global population, with the number of people aged 65 and older, currently at 6.5 million, expected to triple by 2050, reaching 446.6 million, according to the National Institute on Aging.

Neurostimulation Devices for Treating Neurological Disorders

Neurostimulation refers to the use of implanted devices to regulate the activity of the nervous system, offering treatment for conditions such as chronic pain, Parkinson's disease, epilepsy, and depression. In 2020, the global market for neurostimulation devices aimed at chronic pain was valued at approximately $3.5 billion.

Over recent years, the market has shown a compound annual growth rate (CAGR) of around 8-10%, reflecting steady and substantial growth. This upward trend is expected to persist, driven by continuous technological advancements, expanding therapeutic applications, and growing acceptance of neurostimulation as an effective treatment for various neurological disorders.

Benefits of Participation

Speaker Benefits

• Collaborate and engage with the top researchers from around the world.
• Enjoy group registration discounts.
• Get the Outstanding Young Researcher Award.
• Get your abstract published in the conference's open-access proceedings journal.
• Receive a certification and recognition for international speaker participation.
• Take advantage of valuable networking opportunities.
• Gain global exposure for your research on the conference website.
• Enjoy discounts for future conferences, whether in-person or via webinars.
• Benefit from reduced publication fees for participants wishing to publish their research in our open-access journals.
• Boost your research visibility through social media promotion.
• Enjoy refreshments and lunch throughout the conference.

Delegate Benefits

• Actively participate in the Q&A sessions following the speakers' presentations.
• Engage yourself with top researchers from around the world and gain knowledge.
• Receive an International E-Certificate of Honor for participation.
• Enjoy group discounts for teams of two or more participants.
• Benefit from discounts for future conferences, whether in-person or online.
• Take advantage of reduced publication fees for conference participants wishing to publish their research in our open-access journals.
• Enjoy refreshments and lunch throughout the conference.

Past Conference Report

With the invaluable support of the Organizing Committee, we are delighted to reflect on the successful hosting of the "33^rd Euro Congress on Neurologists and Psychiatrists." The conference's theme centered around " Integrating Neurological and Psychiatric Innovations."

We extend our heartfelt gratitude on behalf of the Organizing Committee to all who contributed to the conference's resounding success. Our appreciation goes out to the attendees, delegates, keynote and plenary speakers, business partners, poster presenters, moderator’s chairs, and co-chairs from across the globe.

The conference provided a captivating exploration of recent advancements and emerging technologies in the field of "Neurology, Psychiatry, and Mental Health." The moderators played a pivotal role in ensuring the conference's success, and the speakers delivered insightful and remarkable speeches.